Evaluation of Resectability of Pancreatic Cancer by MDCT
Publisher
Springer Singapore
Reference12 articles.
1. Yanaga Y, Awai K, Nakayama Y, et al. Pancreas: patient body weight tailored contrast material injection protocol versus fixed dose protocol at dynamic CT. Radiology. 2007;245(2):475–82.
2. Fukukura Y, Hamada H, Kamiyama T, et al. Pancreatic adenocarcinoma: analysis of the effect of various concentrations of contrast material. Radiat Med. 2008;26(6):355–61.
3. Ishigami K, Yoshimitsu K, Irie H, et al. Diagnostic value of the delayed phase image for iso-attenuating pancreatic carcinomas in the pancreatic parenchymal phase on multidetector computed tomography. Eur J Radiol. 2009;69:139–46.
4. Takeshita K, Furui S, Takada K. Multidetector row helical CT of the pancreas: value of three-dimensional images, two-dimensional reformations, and contrast-enhanced multiphasic imaging. J Hepato-Biliary-Pancreat Surg. 2002;9:576–82.
5. Nino-Murcia M, Tamm EP, Charnsangavej C, et al. Multidetector-row helical CT and advanced postprocessing techniques for the evaluation of pancreatic neoplasms. Abdom Imaging. 2003;28:366–77.